Physician profile
Timothy Joseph Anders
NPI 1386688364
$13,489.56
in general payments reported to CMS, 2019-2025
46 companies · $2,539 in 2025
The $2,539 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $1,203 · 2021: $1,795 · 2022: $1,914 · 2023: $2,243 · 2024: $2,662 · 2025: $2,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,167 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,167.15 |
| Education | $276.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,272.27 | 2019-2025 | Skyrizi, Rinvoq, Botox |
| Genzyme Corporation | $1,101.08 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,014.04 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $1,003.44 | 2019-2025 | |
| Janssen Biotech, INC. | $999.98 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $886.89 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $825.44 | 2021-2025 | Sotyktu |
| Ucb, INC. | $719.20 | 2019-2025 | Bimzelx, Cimzia |
| Allergan, INC. | $540.84 | 2019-2022 | |
| Lilly USA, LLC | $504.12 | 2019-2025 | Taltz, Ebglyss |
| Amgen INC. | $448.63 | 2020-2025 | Otezla, Otezla |
| Incyte Corporation | $442.29 | 2021-2025 | Opzelura |
| Pfizer INC. | $352.48 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $327.86 | 2019-2024 | Jublia, Cabtreo, Arazlo |
| Biofrontera INC. | $272.64 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.